BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27754593)

  • 1. Age-Dependent Metabolic and Immunosuppressive Effects of Tacrolimus.
    Krenzien F; Quante M; Heinbokel T; Seyda M; Minami K; Uehara H; Biefer HRC; Schuitenmaker JM; Gabardi S; Splith K; Schmelzle M; Petrides AK; Azuma H; Pratschke J; Li XC; ElKhal A; Tullius SG
    Am J Transplant; 2017 May; 17(5):1242-1254. PubMed ID: 27754593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus vs mycophenolate moftile in Tacrolimus based therapy following induction with Antithymocyte globulin promotes regulatory T cell expansion and inhibits RORγt and T-bet expression in kidney transplantation.
    Jamali S; Sarafnejad A; Ahmadpoor P; Nafar M; Karimi M; Eteghadi A; Yekaninejad MS; Amirzargar AA
    Hum Immunol; 2019 Sep; 80(9):739-747. PubMed ID: 30597187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin or tacrolimus alone fails to resist cardiac allograft accelerated rejection mediated by alloreactive CD4(+) memory T cells in mice.
    Liang H; Liao C; Qi Z; Sha C; Xie B; Chen J; Xia J; Wang Y; Yao Q; Zhao Y
    Transpl Immunol; 2010 Feb; 22(3-4):128-36. PubMed ID: 19755159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting age-specific changes in CD4
    Nian Y; Iske J; Maenosono R; Minami K; Heinbokel T; Quante M; Liu Y; Azuma H; Yang J; Abdi R; Zhou H; Elkhal A; Tullius SG
    Aging Cell; 2021 Feb; 20(2):e13299. PubMed ID: 33497523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of resveratrol on Th17 cell-related immune responses under tacrolimus-based immunosuppression.
    Doh KC; Kim BM; Kim KW; Chung BH; Yang CW
    BMC Complement Altern Med; 2019 Mar; 19(1):54. PubMed ID: 30832648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice.
    Zhang Z; Liu L; Tang H; Jiao W; Zeng S; Xu Y; Zhang Q; Sun Z; Mukherjee A; Zhang X; Hu X
    Am J Transplant; 2018 Jul; 18(7):1646-1656. PubMed ID: 29316256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of AEB071 (sotrastaurin) with tacrolimus on rat heterotopic cardiac allograft rejection and survival.
    Fang YH; Joo DJ; Lim BJ; Huh KH; Kim MS; Suh H; Kim YS
    J Surg Res; 2011 Nov; 171(1):e133-7. PubMed ID: 21816421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects and mechanisms of tacrolimus on development of murine Th17 cells.
    Zhang XJ; Kang YD; Xiao L; Li RD; Ding GS; Wang ZX; Fu ZR
    Transplant Proc; 2010 Nov; 42(9):3779-83. PubMed ID: 21094856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppressive effects of DTCM-G, a novel inhibitor of the mTOR downstream signaling pathway.
    Shibasaki S; Yamashita K; Goto R; Wakayama K; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Umezawa K; Todo S
    Transplantation; 2013 Feb; 95(4):542-50. PubMed ID: 23269193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate Mofetil.
    Traitanon O; Mathew JM; Shetty A; Bontha SV; Maluf DG; El Kassis Y; Park SH; Han J; Ansari MJ; Leventhal JR; Mas V; Gallon L
    PLoS One; 2019; 14(5):e0216300. PubMed ID: 31136582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin Prolongs Graft Survival and Induces CD4+IFN-γ+IL-10+ Regulatory Type 1 Cells in Old Recipient Mice.
    Quante M; Heinbokel T; Edtinger K; Minami K; Uehara H; Nian Y; Azuma H; Abdi R; Elkhal A; Tullius SG
    Transplantation; 2018 Jan; 102(1):59-69. PubMed ID: 28777210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective CD8 Signaling Pathways Delay Rejection in Older Recipients.
    Bedi DS; Krenzien F; Quante M; Uehara H; Edtinger K; Liu G; Denecke C; Jurisch A; Kim I; Li H; Yuan X; Ge X; ElKhal A; Tullius SG
    Transplantation; 2016 Jan; 100(1):69-79. PubMed ID: 26356176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG; Liu Z; Wu Y
    Transpl Immunol; 2005 Oct; 15(1):9-16. PubMed ID: 16223668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production.
    Jiang H; Wynn C; Pan F; Ebbs A; Erickson LM; Kobayashi M
    Transplantation; 2002 Jun; 73(11):1808-17. PubMed ID: 12085006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD4+ T Cell Help Is Mandatory for Naive and Memory Donor-Specific Antibody Responses: Impact of Therapeutic Immunosuppression.
    Chen CC; Koenig A; Saison C; Dahdal S; Rigault G; Barba T; Taillardet M; Chartoire D; Ovize M; Morelon E; Defrance T; Thaunat O
    Front Immunol; 2018; 9():275. PubMed ID: 29515582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant reduction of acute cardiac allograft rejection by selective janus kinase-1/3 inhibition using R507 and R545.
    Deuse T; Hua X; Taylor V; Stubbendorff M; Baluom M; Chen Y; Park G; Velden J; Streichert T; Reichenspurner H; Robbins RC; Schrepfer S
    Transplantation; 2012 Oct; 94(7):695-702. PubMed ID: 22971540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ASP2409, A Next-Generation CTLA4-Ig, Versus Belatacept in Renal Allograft Survival in Cynomolgus Monkeys.
    Song L; Ma A; Dun H; Hu Y; Fujii Y; Kinugasa F; Oshima S; Higashi Y; Daloze P; Chen H
    Am J Transplant; 2017 Mar; 17(3):635-645. PubMed ID: 27598231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Immunosuppressant, Luteolin, Modulates Alloimmunity and Suppresses Murine Allograft Rejection.
    Ye S; Liu H; Chen Y; Qiu F; Liang CL; Zhang Q; Huang H; Wang S; Zhang ZD; Lu W; Dai Z
    J Immunol; 2019 Dec; 203(12):3436-3446. PubMed ID: 31732527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.